학술논문
Ombipepimut dosing emulsion (ODE) + bevacizumab (bev) vs bev alone in patients (pts) with recurrent or progressive glioblastoma (rGBM).
Document Type
Article
Author
Goldlust, Samuel Aaron; Chang, Jong Hee; Narita, Yoshitaka; Welch, Mary Roberta; Green, Richard M.; Drappatz, Jan; Piccioni, David Eric; Kim, Yu Jung; Melear, Jason M.; Tanaka, Shota; Wei, Kuo-Chen; Fink, Karen L.; Pitz, Marshall W.; Cloughesy, Timothy Francis; de Groot, John Frederick; McClellan, Nanci; Hitron, Matthew; Xu, Bo; Jin, Bo; Lebedinsky, Claudia
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2022-2022, 1p
Subject
Language
ISSN
0732183X